Key statistics
On Monday, Novozymes A/S (NZM2:BRN) closed at 50.53, 5.60% above its 52-week low of 47.85, set on Oct 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 50.53 |
|---|---|
| High | 50.53 |
| Low | 50.53 |
| Bid | 50.18 |
| Offer | 50.43 |
| Previous close | 50.53 |
| Average volume | -- |
|---|---|
| Shares outstanding | 414.56m |
| Free float | 295.02m |
| P/E (TTM) | 40.27 |
| Market cap | 155.67bn DKK |
| EPS (TTM) | 9.32 DKK |
| Annual div (ADY) | 0.7901 CHF |
|---|---|
| Annual div yield (ADY) | 1.56% |
| Div ex-date | Aug 25 2025 |
| Div pay-date | Aug 27 2025 |
| Next div ex-date | Mar 24 2026 |
| Next div pay-date | Mar 26 2026 |
Data delayed at least 15 minutes, as of Jan 26 2026.
More ▼
Announcements
- Trading by management and close relations of management
- Trading by management and close relations of management
- Invitation to the 2026 Annual General Meeting
- Trading by management and close relations of management
- Novonesis delivered strong organic sales growth of 7% in 2025
- Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees
- Novonesis' Annual Report 2025
- Trading by management and close relations of management
- Trading by management and close relations of management
- Major shareholder announcement
More ▼
